Importance Bladder cancer is a common malignancy in women and is the fourth most
common malignancy in men. Bladder cancer ranges from unaggressive and usually …

This Seminar presents the current best practice for the diagnosis and management of
bladder cancer. The scope of this Seminar ranges from current challenges in pathology …

Importance Due to the ongoing bacillus Calmette-Guérin (BCG) shortage, sequential
intravesical gemcitabine and docetaxel has been increasingly used as first-line therapy for …

The NCCN Guidelines for Bladder Cancer provide recommendations for the diagnosis,
evaluation, treatment, and follow-up of patients with bladder cancer and other urinary tract …

Background Although radical cystectomy (RC) is the standard of care for patients with
bacillus Calmette-Guérin (BCG)-unresponsive high-risk non–muscle-invasive bladder …

Purpose: The purpose of this American Urological Association (AUA)/Society of Urologic
Oncology (SUO) guideline amendment is to provide a useful reference on the effective …

Purpose: Bacillus Calmette-Guérin (BCG) is currently recommended as adjuvant therapy
following complete transurethral resection of bladder tumor for high-risk nonmuscle-invasive …

Introduction Intravesical gemcitabine and docetaxel (Gem/Doce) has been established as a
safe and efficacious salvage treatment for recurrent NMIBC since 2015. Despite widespread …

Urothelial carcinoma (UC), the sixth most common cancer in Western countries, includes
upper tract urothelial carcinoma (UTUC) and bladder carcinoma (BC) as the most common …

Background and objective There has been a recent surge in the development of agents for
bacillus Calmette-Guérin–unresponsive (BCG-U) non–muscle-invasive bladder cancer …